Development of a chromophore-solid phase peptide reaction assay (C-SPRA) for assessing skin sensitization in vitro.

Analyst

Medical Device Division, Innovation and Business Development Headquarters, Daicel Corporation, Minato-ku, Tokyo 108-8230, Japan.

Published: May 2020

We developed an in vitro chromophore-solid phase peptide reaction assay (C-SPRA) using microbead-immobilized peptides and chromophores. Peptide-resins (microbeads) reacted with 14 representative chemicals to demonstrate the test's capacity to predict skin sensitization. C-SPRA enables accurate and high-throughput assessments of various chemicals, including poorly water-soluble sensitizers that are regarded as weakly potent by other methods.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c9an02514fDOI Listing

Publication Analysis

Top Keywords

chromophore-solid phase
8
phase peptide
8
peptide reaction
8
reaction assay
8
assay c-spra
8
skin sensitization
8
development chromophore-solid
4
c-spra assessing
4
assessing skin
4
sensitization vitro
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!